UK markets close in 3 hours 37 minutes

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
546.52-2.22 (-0.40%)
At close: 04:03PM EDT
546.52 +0.35 (+0.06%)
After hours: 04:28PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 16.15B
Enterprise value 15.57B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) 1.07
Price/sales (ttm)5.74
Price/book (mrq)1.83
Enterprise value/revenue 5.42
Enterprise value/EBITDA -6.32

Trading information

Stock price history

Beta (5Y monthly) 0.95
52-week change 3-29.98%
S&P500 52-week change 3-3.39%
52-week high 3832.70
52-week low 3462.61
50-day moving average 3515.62
200-day moving average 3599.30

Share statistics

Avg vol (3-month) 3172.65k
Avg vol (10-day) 3121.32k
Shares outstanding 524.63M
Implied shares outstanding 6N/A
Float 821.24M
% held by insiders 114.43%
% held by institutions 182.63%
Shares short (28 Jul 2022) 4335.35k
Short ratio (28 Jul 2022) 41.95
Short % of float (28 Jul 2022) 41.59%
Short % of shares outstanding (28 Jul 2022) 41.13%
Shares short (prior month 29 Jun 2022) 4388.6k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 307 Mar 2002

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin -67.66%
Operating margin (ttm)20.68%

Management effectiveness

Return on assets (ttm)2.67%
Return on equity (ttm)-18.93%

Income statement

Revenue (ttm)2.87B
Revenue per share (ttm)96.13
Quarterly revenue growth (yoy)-3.50%
Gross profit (ttm)1.67B
EBITDA 725.63M
Net income avi to common (ttm)-1.94B
Diluted EPS (ttm)-3.39
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.97B
Total cash per share (mrq)66.26
Total debt (mrq)1.39B
Total debt/equity (mrq)15.60
Current ratio (mrq)5.30
Book value per share (mrq)300.45

Cash flow statement

Operating cash flow (ttm)484.8M
Levered free cash flow (ttm)340.62M